Simplera™ CGM US vs MiniMed
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Simplera™ CGM US
This system helps manage diabetes by displaying continuous glucose monitoring (CGM) values on a mobile device. It sends alerts for glucose events and tracks how lifestyle factors affect glucose levels. The app requires a compatible sensor and is intended for individuals participating in clinical research.
- Continuous glucose monitoring (CGM) display
- Glucose event alerts
- Tracks lifestyle impact on glucose
- Requires Simplera sensor
- Uploads data to CareLink™ Personal
- Clinical research use only
Read full descriptionHide full description
The Simplera™ continuous glucose monitoring (CGM) system helps people manage diabetes. CGM is a technology that lets users view glucose values throughout the day, sends alerts for glucose events on a mobile device, and shows the effects life has on glucose levels. The Simplera™ CGM uses a Simplera™ sensor with Bluetooth™ that converts small amounts of glucose from under the skin into an electronic signal. This signal is used to provide sensor glucose (SG) values to the Simplera™ app on a compatible device. The Simplera™ app provides alerts based on SG levels and the user can enter data such as insulin, meals, exercise, blood glucose (BG) values, and upload information to CareLink™ Personal. The Simplera™ app requires the Simplera™ sensor to function. The Simplera™ CGM provides information that is used for diabetes management but does not provide any direct therapy. In order to access the list of the supported mobile devices and operating systems, go to medtronicdiabetes.com/Device-Compatibility. The clinical configuration of the app is intended for use in clinical research only. It is available only to individuals who have consented to take part in clinical research activities with Medtronic. Clinical studies where this app will be used will follow their own regulatory process and obtain requisite approvals. IMPORTANT NOTE: The Simplera™ system requires a prescription and is indicated for the management of diabetes in persons ages 18 years and older. The sensor is indicated for up to 6 days of use plus an additional 24-hour grace period. The Simplera™ system does not require calibration. Blood glucose (BG) readings are required (1) during the first 12 hours of use, (2) if no sensor data is available, (3) when symptoms do not match the sensor glucose (SG) value, and (4) when taking certain medications. Not taking BG readings as indicated can lead to incorrect sensor glucose readings, over-administration of insulin, and possible hypoglycemia. Proper settings and hearing are also required. Sensor use can also result in skin irritation, bruising, discomfort, redness, bleeding, and infection, and sensors in general also pose a choking risk to young children, which can result in serious injury or death. For complete details see https://www.medtronicdiabetes.com/support/download-library/user-guides and https://bit.ly/SimpleraSafety. This app store should not be used as your first point of contact to resolve technical or customer services issues. In order to protect your privacy and personal information, and promptly resolve any technical or customer services issues you are having with any Medtronic product, please contact your local Medtronic representative. This app is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment. ©2026 Medtronic. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. ™*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company. Apple, App Store, and Apple Watch are trademarks of Apple Inc., registered in the U.S. and other countries and regions. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license. Other trademarks and trade names are those of their respective owners.
MiniMed
Manage your diabetes therapy with this app, which connects to your pump system to monitor glucose, adjust insulin, and receive alerts. View trends, track history, and get reminders for key actions, simplifying diabetes management.
- Monitor glucose levels
- Adjust insulin delivery
- Receive real-time alerts
- View glucose trends
- Track daily history
- Get action reminders
- Upload data to CareLink
Read full descriptionHide full description
Manage your diabetes therapy with the MiniMed™ app! The MiniMed app connects to your MiniMed Flex™ pump system, letting you monitor glucose, adjust insulin delivery, and receive real-time alerts — all from your smartphone. View trends, track daily history, and get reminders for important actions. A new approach to making diabetes management simpler. The app guides you through the startup process and provides an overview of data received from the MiniMed Flex pump and sensor. The MiniMed app is your primary source of information about your therapy and for controlling insulin delivery. Your data is automatically uploaded to CareLink™ software, simplifying the process of sharing information with your healthcare team and care partners. Important: The MiniMed app is only compatible with the MiniMed Flex system, it does not work with other MiniMed pumps. The MiniMed app should only be used with supported mobile devices and operating systems. To access the list of the supported mobile devices and operating systems, go to https://www.medtronicdiabetes.com/app-check The MiniMed Flex system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed Flex system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera Sync™ sensor and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP. MiniMed Flex system is for type 1 ages 7 and over and type 2 ages 18 and over. Prescription required. WARNING: Do not use SmartGuard™ feature for people who require less than 8 units or more than 250 units of insulin/day. For additional safety information and user guides, see https://bit.ly/MiniMedRisks. WARNING: Do not use the MiniMed Flex system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed Flex system. Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed Flex system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, see https://bit.ly/MiniMedRisks. ©2026 MiniMed. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. ™*Third-party brands are trademarks of their respective owners. All other brands are trademarks of the MiniMed company.
Screenshots
Verdict
The clearest difference is rating: MiniMed at 4.0 against Simplera™ CGM US's 2.0. MiniMed also leads on ratings volume (81 vs 4). Simplera™ CGM US's advantage is iOS requirement (15.0 vs 17.0). On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
MiniMed holds the better App Store score, 4.0 against 2.0. That said, the two scores are not equally well evidenced: MiniMed has 81 ratings behind it against 4, so its average is the more settled of the two.
Simplera™ CGM US ships an update every 4 months, MiniMed every 2 months. The most recent releases landed on November 3, 2026 and November 15, 2026 respectively.
| Parameter | Simplera™ CGM US | MiniMed |
|---|---|---|
| Price | Free | Free |
| Rating | 2.0 (4 ratings) | 4.0 (81 ratings) — better |
| Positive reviews | — | 85.7% of reviews |
| Number of ratings | 4 | 81 — better |
| Update frequency | Every 4 months | Every 2 months — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPod, Apple Watch — better | iPhone, Apple Watch |
| Requires iOS | 15.0 — better | 17.0 |
| Further details — not scored | ||
| Size | 108 MB | 203 MB |
| Age rating | 17+ | 9+ |
| Developer | Medtronic, Inc. | MiniMed |
In-app purchases
Simplera™ CGM US
No in-app purchases
MiniMed
No in-app purchases
Questions
Is Simplera™ CGM US free?
Is MiniMed free?
Which has better reviews, Simplera™ CGM US or MiniMed?
Do Simplera™ CGM US or MiniMed have ads?
Which is updated more often, Simplera™ CGM US or MiniMed?
Other comparisons















